Compare Regeneron Pharmaceuticals Inc (REGN) vs Steel Dynamics Inc. (STLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Steel Dynamics Inc. — how do they compare? Regeneron Pharmaceuticals Inc trades at $746.12 (market cap $76.14B), while Steel Dynamics Inc. trades at $238 (market cap $33.57B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 2.3× Steel Dynamics Inc.'s market cap, and Steel Dynamics Inc. pays the higher dividend (0.91%). Which is the better fit depends on your goals — on Pluang, investors hold Regeneron Pharmaceuticals Inc for 107 Days and Steel Dynamics Inc. for 1 Days on average.
| REGN | STLD | |
|---|---|---|
Market Cap | $76.14B | $33.57B |
Volume | 500,239 | 852,460 |
Sector | Health | Basic Materials |
52-Week High | $852.03 | $282.76 |
52-Week Low | $557.73 | $141.23 |
Typical Hold Time | 107 Days | 1 Days |
Enterprise Value | $70.85B | $37.18B |
Dividend Yield | 0.51% | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Regeneron Pharmaceuticals (REGN) trades at $747.21, up 0.69% with strong recent earnings beats. The stock shows bearish technical signals but maintains robust fundamentals with 84.86% gross margins and consistent revenue growth. Recent news highlights a major $8 billion immunology alliance expansion with Sanofi, providing significant upfront and milestone payments. Analyst consensus remains strongly bullish with 69% buy ratings and an $849.84 price target, representing 13.7% upside potential from current levels.
REGN presents a compelling growth story with strong profitability and strategic partnerships, though technical indicators suggest near-term consolidation. The expanded Sanofi collaboration and promising clinical trial data provide catalysts, while competition in key therapeutic areas and reliance on blockbuster drugs represent ongoing risks. Wall Street optimism remains high given the company's execution track record and pipeline potential.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Steel Dynamics Inc.
Steel Dynamics produces steel, processes recycled metals, and provides steel-fabrication services. Its operations use recycled scrap as a key input and also include aluminum products.
Read more on STLD →
